-
NMPA Announcement on the Emergency Approval Procedure for Medical Devices
2021-12-29
National Medical Products Administration organized to revise the Emergency Approval Procedure for Medical Devices, which is issued and take effect as of December 29, 2021.
-
NMPA Announcement on Issuing the Provisions for Administration of Self-Test for Medical Device Registration
2021-10-22
The NMPA organized to formulate the Provisions for Self-Test for Medical Device Registration, The Provisions for Self-Test for Medical Device Registration was issued and implemented on October 22, 2021.
-
NMPA Announcement on Revising the Package Insert of Antiviral Syrup, Capsules, Soft Capsules, Pills (Concentrated Pills), Dropping Pills, Tablets, Effervescent Tablets, Chewable Tablet, Oral Liquid, And Granules
2021-10-12
The NMPA decided to revise such items as [Adverse reactions], [Contraindications] and [Precautions] in the package inserts of antiviral syrup, capsules, soft capsules, pills (concentrated pills), dropping pills, tablets, effervescent tablets, chewable tablet, oral liquid, and granules.
-
NMPA Announcement on Issuing the Provisions for the Supervision and Administration of Children's Cosmetics
2021-10-08
The National Medical Products Administration has organized to formulate the Provisions for the Supervision and Administration of Children's Cosmetics, which was issued on October 8. The issues related to the implementation of the Provisions are hereby announced as follows.
-
NPMA Announcement on Implementing the Application with Electronic Common Technical Documents
2021-09-30
The National Medical Products Administration comprehensively carried out and promoted the application with electronic common technical document (eCTD). The relevant issues related to eCTD application are hereby announced as follows.
-
NMPA Announcement on Matters Concerning the Implementation of the Provisions for Medical Device Registration and Filing and the Provisions for In-vitro Diagnostic Reagent Registration and Filing
2021-09-29
The Provisions for Medical Device Registration and Filing (SAMR Decree No.47) and the Provisions for In-vitro Diagnostic Reagent Registration and Filing (SAMR Decree No.48) were issued and implemented as of October 1, 2021.